menu
    • menu

    Company profile for BEDFORD LABS

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ben Venue Laboratories, Inc. (Ben Venue) of Bedford, Ohio, has decided to cease production by the end of 2013. Despite the ongoing support of the U.S. Food and Drug Administration (FDA), the tremendous dedication of employees, and significant investments in facility upgrades, the company cannot return to sustainable production. Although interim controls implemented to assure product quality have been effective to date, in the ...
    Ben Venue Laboratories, Inc. (Ben Venue) of Bedford, Ohio, has decided to cease production by the end of 2013. Despite the ongoing support of the U.S. Food and Drug Administration (FDA), the tremendous dedication of employees, and significant investments in facility upgrades, the company cannot return to sustainable production. Although interim controls implemented to assure product quality have been effective to date, in the long term, they are not sustainable. The magnitude of continued investment and time required to overcome the systemic manufacturing challenges is not viable. Given the age and condition of some of our facilities, combined with the findings from our third-party current Good Manufacturing Practice (cGMP) experts and ongoing remediation needs, Ben Venue projects, in addition to the more than $350 million invested to date, significant additional cumulative operating losses of approximately $700 million over the next five years. The effort, magnitude of investment, and additional years required to remediate the facility before Ben Venue can return to sustainable production is not feasible. Ben Venue understands the importance of the drugs the company produces, and will work to help ensure that these critical medicines continue to reach the patients who need them. The closure will affect all of Ben Venue’s employees (approximately 1,100) over a phased reduction starting this month and continuing into 2014 as Ben Venue executes wind-down activities. Boehringer Ingelheim recognizes the importance of Bedford Laboratories, Ben Venue’s generic sterile injectables business, and is exploring strategic options to try to continue the supply of these products to patients. Ben Venue has notified the FDA of this difficult decision, and is diligently working to minimize the potential impacts this decision may have on patients, providers and employees.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BEDFORD LABSUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Northfield Road Bedford, OH 44146 U.S.A.
    Telephone
    Telephone
    +1 732 542 1191
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.bedfordlabs.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anika Announces Third Quarter 2024 Results Conference Call Date
    Anika Announces Third Quarter 2024 Results Conference Call Date

    17 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/17/2965205/28467/en/Anika-Announces-Third-Quarter-2024-Results-Conference-Call-Date.html

    GLOBENEWSWIRE
    17 Oct 2024
    Share Share
    Biotech Executive Meenu Chhabra Karson joins Bedford Transearch Advisory Board
    Biotech Executive Meenu Chhabra Karson joins Bedford Transearch Advisory Board

    30 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotech-executive-meenu-chhabra-karson-joins-bedford-group-transearch-advisory-board-302047272.html

    PR NEWSWIRE
    30 Jan 2024
    Share Share
    Xellia Expects Ex-Boehringer Sterile Plant to be Ready for Production in 2018
    Xellia Expects Ex-Boehringer Sterile Plant to be Ready for Production in 2018

    16 Nov 2016

    // Eric Palmer FIERCE PHARMA

    http://www.fiercepharma.com/manufacturing/xellia-expects-ex-boehringer-sterile-plant-to-be-ready-for-production-2018

    Eric Palmer FIERCE PHARMA
    16 Nov 2016
    Share Share
    Bedford recalls Testosterone Cypionate due to Lack of assurance of sterility
    Bedford recalls Testosterone Cypionate due to Lack of assurance of sterility

    21 Oct 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0046-2016&w=10212015&lang=eng

    FDA
    21 Oct 2015
    Share Share
    Bedford recalls P-P-P(COBAL) 30-1-5/mL due to Lack of assurance sterility
    Bedford recalls P-P-P(COBAL) 30-1-5/mL due to Lack of assurance sterility

    21 Oct 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0048-2016&w=10212015&lang=eng

    FDA
    21 Oct 2015
    Share Share
    Still no plans to resume manufacturing at former Ben Venue plant
    Still no plans to resume manufacturing at former Ben Venue plant

    17 Aug 2015

    // Dan Rosenberg IN-PHARMA TECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/Still-no-plans-to-resume-manufacturing-at-former-Ben-Venue-plant

    Dan Rosenberg IN-PHARMA TECHNOLOGIST
    17 Aug 2015
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Ben Venue Laboratories Inc. and get a quotation

    Ben Venue Laboratories Inc. is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Cyclophosphamide bulk offered by Ben Venue Laboratories Inc.

    Find a price of Methotrexate bulk offered by Ben Venue Laboratories Inc.

    Find a price of PEG-L-ASPARAGINASE bulk offered by Ben Venue Laboratories Inc.

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search